Control Bionics Ltd. ( ($AU:CBL) ) has shared an update. Control Bionics Limited has issued 8,443,747 fully paid ordinary shares on 31 December ...

Control Bionics Ltd. ( ($AU:CBL) ) has shared an update. Control Bionics Limited has lodged a notice with the ASX for a proposed issue of up to ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd. has presented its next-generation assistive technology and data measurement solutions, aiming to enhance user experience and ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the ...

MILFORD, Ohio and NEW SOUTH WALES, Australia, April 8, 2021 /PRNewswire/ — Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering ...

Revenue: AU$6.14m (up 15% from FY 2024). Net loss: AU$6.11m (loss widened by 3.3% from FY 2024). AU$0.023 loss per share. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% ...

(from left) Inventor James Schorey and CEO Rob Wong of Control Bionics show off the new wearable device. A Milford company is back with an updated communication tool for ALS and other "locked-in" ...

PERTH, Australia – Med-tech company Control Bionics began trading on the Australian Securities Exchange (ASX:CBL) Dec. 7 in an IPO that saw the company raise AU$15 million (US$11.25 million).